Differences in breast cancer risk factors by tumor marker subtypes among premenopausal Vietnamese and Chinese women.
暂无分享,去创建一个
A. Trentham-Dietz | P. Newcomb | D. Allred | R. Love | S. Mohsin | H. Nichols | J. Hampton | Pham Thi Hoang Anh | Polly A. Newcomb | Pham Thi Hoang Anh
[1] I. Bleiweiss,et al. Proliferative indices and oncoprotein expression in benign and malignant breast biopsies , 1995, Annals of Surgical Oncology.
[2] Graham A Colditz,et al. Risk factors for breast cancer according to estrogen and progesterone receptor status. , 2004, Journal of the National Cancer Institute.
[3] J. Potter,et al. The shape of age–incidence curves of female breast cancer by hormone-receptor status , 1999, Cancer Causes & Control.
[4] D. Parkin,et al. Time trends in cancer mortality in China: 1987–1999 , 2003, International journal of cancer.
[5] F. Berrino,et al. Role of hormonal risk factors in HER2-positive breast carcinomas , 2003, British Journal of Cancer.
[6] D. DeMets,et al. Her-2/neu overexpression and response to oophorectomy plus tamoxifen adjuvant therapy in estrogen receptor-positive premenopausal women with operable breast cancer. , 2003, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[7] D. Thomas,et al. Breast cancer in relation to induced abortions in a cohort of Chinese women , 2002, British Journal of Cancer.
[8] Janet E Olson,et al. Interaction of dietary folate intake, alcohol, and risk of hormone receptor-defined breast cancer in a prospective study of postmenopausal women. , 2002, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.
[9] D. DeMets,et al. Oophorectomy and tamoxifen adjuvant therapy in premenopausal Vietnamese and Chinese women with operable breast cancer. , 2002, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[10] J. Cerhan,et al. Interaction of waist/hip ratio and family history on the risk of hormone receptor-defined breast cancer in a prospective study of postmenopausal women. , 2002, American journal of epidemiology.
[11] S. Gapstur,et al. Alcohol and breast cancer: review of epidemiologic and experimental evidence and potential mechanisms. , 2001, JAMA.
[12] J. Ferlay,et al. Globocan 2000 : cancer incidence, mortality and prevalence worldwide , 2001 .
[13] N. Chatterjee,et al. Tumor variants by hormone receptor expression in white patients with node-negative breast cancer from the surveillance, epidemiology, and end results database. , 2001, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[14] T. Sellers,et al. Association of menstrual and reproductive factors with breast cancer risk: Results from the Shanghai breast cancer study , 2000, International journal of cancer.
[15] L. Bernstein,et al. Body size, physical activity, and breast cancer hormone receptor status: results from two case-control studies. , 2000, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.
[16] R C Millikan,et al. Hormone-related factors and risk of breast cancer in relation to estrogen receptor and progesterone receptor status. , 2000, American journal of epidemiology.
[17] R. Millikan,et al. Risk of breast cancer according to the status of HER-2/neu oncogene amplification. , 2000, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.
[18] M. Barbareschi,et al. Prognostic value of estrogen receptor status can be improved by combined evaluation of p53, Bcl2 and PgR expression: an immunohistochemical study on breast carcinoma with long-term follow-up. , 1999, International journal of oncology.
[19] C. Osborne,et al. Biologic markers as predictors of clinical outcome from systemic therapy for primary operable breast cancer. , 1999, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[20] M. J. van de Vijver,et al. The utility of mitotic index, oestrogen receptor and Ki-67 measurements in the creation of novel prognostic indices for node-negative breast cancer. , 1999, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.
[21] N. Sadick,et al. Estrogen and progesterone receptors: their role in postsclerotherapy angiogenesis telangiectatic matting (TM). , 1999, Dermatologic surgery : official publication for American Society for Dermatologic Surgery [et al.].
[22] W. Thompson,et al. Oral contraceptive use and other risk factors in relation to HER-2/neu overexpression in breast cancer among young women. , 1999, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.
[23] C K Osborne,et al. Estrogen receptor status by immunohistochemistry is superior to the ligand-binding assay for predicting response to adjuvant endocrine therapy in breast cancer. , 1999, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[24] Jacques Ferlay,et al. Estimates of the worldwide incidence of 25 major cancers in 1990 , 1999, International journal of cancer.
[25] A. Jemal,et al. Global cancer statistics , 2011, CA: a cancer journal for clinicians.
[26] M Dosemeci,et al. Occupational risk factors for breast cancer among women in Shanghai. , 1998, American journal of industrial medicine.
[27] J. Ross,et al. The HER‐2/neu Oncogene in Breast Cancer: Prognostic Factor, Predictive Factor, and Target for Therapy , 1998, Stem cells.
[28] D. Parkin,et al. Cancer incidence in Ho Chi Minh City, Viet Nam, 1995–1996 , 1998, International journal of cancer.
[29] W. Willett,et al. Risk factors for breast cancer in women with a breast cancer family history. , 1998, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.
[30] F. Berrino,et al. Alcohol consumption and total estradiol in premenopausal women. , 1998, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.
[31] F. Speizer,et al. Alcohol and breast cancer in women: a pooled analysis of cohort studies. , 1998, JAMA.
[32] D. Allred,et al. Prognostic and predictive factors in breast cancer by immunohistochemical analysis. , 1998, Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc.
[33] S. Martino,et al. HER-2 expression and response to tamoxifen in estrogen receptor-positive breast cancer: a Southwest Oncology Group Study. , 1998, Clinical cancer research : an official journal of the American Association for Cancer Research.
[34] W. Willett,et al. Body size and risk of breast cancer. , 1997, American journal of epidemiology.
[35] A. Bianco,et al. c-erb B2 overexpression decreases the benefit of adjuvant tamoxifen in early-stage breast cancer without axillary lymph node metastases. , 1996, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[36] M. Sliwkowski,et al. HER-2 tyrosine kinase pathway targets estrogen receptor and promotes hormone-independent growth in human breast cancer cells. , 1995, Oncogene.
[37] J. Cerhan,et al. Progesterone and estrogen receptors and mammary neoplasia in the Iowa Women's Health Study: how many kinds of breast cancer are there? , 1995, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.
[38] A. Schindler,et al. Level of c-erbB-2 oncoprotein in the homogenate of malignant and benign breast tumor samples. , 1995, European journal of gynaecological oncology.
[39] P. Nasca,et al. Alcohol consumption and breast cancer: estrogen receptor status and histology. , 1994, American journal of epidemiology.
[40] P. Taylor,et al. Effects of alcohol consumption on plasma and urinary hormone concentrations in premenopausal women. , 1993, Journal of the National Cancer Institute.
[41] W. McGuire,et al. Prognostic factors and therapeutic decisions in axillary node-negative breast cancer. , 1992, Annual review of medicine.
[42] W. Willett,et al. The Reliability of Self-Reported Alcohol Consumption in the Remote Past , 1992, Epidemiology.
[43] W. McGuire,et al. Prognostic factors and treatment decisions in axillary-node-negative breast cancer. , 1992, The New England journal of medicine.
[44] B. Ljung,et al. The HER2 (c-erbB-2) oncogene is frequently amplified in in situ carcinomas of the breast. , 1992, Oncogene.
[45] A. Hart,et al. Differences in breast cancer risk factors to neu (c-erbB-2) protein overexpression of the breast tumor. , 1992, Cancer research.
[46] D. DeMets,et al. Effects of tamoxifen on cardiovascular risk factors in postmenopausal women. , 1991, Annals of internal medicine.
[47] M. Fernö,et al. Her-2/neu and INT2 proto-oncogene amplification in malignant breast tumors in relation to reproductive factors and exposure to exogenous hormones. , 1991, Journal of the National Cancer Institute.
[48] Z. Rayter,et al. Steroid receptors in breast cancer , 1991, British Journal of Surgery.
[49] M. J. van de Vijver,et al. The molecular biology of breast cancer. , 1991, Biochimica et biophysica acta.
[50] B. Henderson,et al. Risk factors for breast cancer in Chinese women in Shanghai. , 1988, Cancer research.
[51] B. Henderson,et al. Risk factors for breast cancer in Tianjin, People's Republic of China. , 1985, National Cancer Institute monograph.
[52] G. Greene,et al. Monoclonal antibodies localize oestrogen receptor in the nuclei of target cells , 1984, Nature.
[53] J. Wittliff. Steroid‐hormone receptors in breast cancer , 1984, Cancer.
[54] Ketcham As,et al. Risk factors in breast cancer. , 1975 .
[55] C. D. HAAGENSEN,et al. Diseases of the Breast , 1972 .